68Ga-FAPI PET/CT Prevents Futile Surgery and Demonstrates Tumor Biology in Patients with Pancreatic Ductal Adenocarcinoma

William McGahan, Alexa Chadwick, Karen Lindsay, Brook Gulhane, Melissa J Latter, Thomas O’Rourke, Paul A […]

2025-12-02T18:45:03+00:009, Oct 2025|Publications|

Revealing the hidden: A systematic review and meta-analysis of FAPI-based tracers imaging for brain metastatic lesions

Sajjad Sadeghpour, Atena Aghaee, Hojjat Ahmadzadehfar, Alessio Rizzo, Giorgio Treglia, Ramin Sadeghi

2025-12-02T18:55:12+00:007, Oct 2025|Publications|

SOFIE Biosciences Prepares Launch of Two [18F]FAPI-74 Phase 3 Studies, following successful FDA engagement

  • Favorable End-of-Phase 2 meeting with U.S. FDA for [18F]FAPI-74 for GI cancers
  • Primary and […]
2025-10-15T16:42:09+00:001, Oct 2025|News|

Focus on FAPI Newsletter – Q3 2025

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

2025-12-03T20:10:42+00:003, Sep 2025|Newsletter|

[68Ga]Ga-API-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial

Kim M Pabst, Manuel M Weber, Christina Laschinsky, Patrick Sandach, Timo Bartel, Alina T Küper, […]

2025-10-15T16:40:43+00:004, Aug 2025|Publications|

90 Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors

Helena Lanzafame, Christoph E Heilig, Eva Wardelmann, Mélanie Desaulniers, Kim Magaly Pabst, Ilektra Antonia Mavroeidi, […]

2025-09-04T19:02:23+00:0024, Jul 2025|Publications|

Early image acquisition 68Ga-FAPI-46-PET/CT in prone position is promising in the workup of rectosigmoid and anal carcinoma 

D Ufton, J Heilinger, H Weis, T Fischer, K Schomäcker, C Bruns, G Dieplinger, H […]

2025-10-15T16:40:43+00:0016, Jul 2025|Publications|

Current State of FAP Targeting Radioligands in Oncology

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
SOFIE Educational Webinar Series
June 18, 2025 – 

2026-01-11T22:33:33+00:0018, Jun 2025|Webinars|

Focus on FAPI Newsletter – Q2 2025

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

2025-12-03T20:10:27+00:009, Jun 2025|Newsletter|
Go to Top